CVE:QPTQuest PharmaTech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Quest PharmaTech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.11 -449,575.89 (-100.00 %) (As of 04/3/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.11Now: C$0.11▼C$0.1150-Day RangeC$0.06MA: C$0.11▼C$0.1452-Week RangeC$0.06Now: C$0.11▼C$0.18Volume3,000 shsAverage Volume34,441 shsMarket CapitalizationC$18.41 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartEarningsHeadlinesSocial Media Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. It operates in two segments, Biopharmaceutical/Pharmaceutical Products and Consumer/Cosmetic Products. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant. Its lead product candidate is Oregovomab, a monoclonal antibody, which is in Phase II clinical trial for the treatment of ovarian cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications; and markets Bellus Skin serum, an anti-wrinkle skin care product, as well as develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Quest PharmaTech. Previous Next 2.1 Community Rank Outperform VotesQuest PharmaTech has received 44 “outperform” votes. (Add your “outperform” vote.)Underperform VotesQuest PharmaTech has received 59 “underperform” votes. (Add your “underperform” vote.)Community SentimentQuest PharmaTech has received 57.28% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Quest PharmaTech and other stocks. Vote “Outperform” if you believe QPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe QPT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldQuest PharmaTech does not currently pay a dividend.Dividend GrowthQuest PharmaTech does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Quest PharmaTech insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest PharmaTech is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest PharmaTech is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.42 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:QPT Previous Symbol CUSIPN/A CIKN/A Webhttp://www.questpharmatech.com/ Phone+1-780-4481400Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.06Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$38,871.00 Price / Sales473.69 Cash FlowC$0.00 per share Price / Cash Flow24.00 Book ValueC($0.08) per share Price / Book-1.38Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares167,389,000Market CapC$18.41 million Next Earnings Date6/4/2020 (Estimated) OptionableNot Optionable Receive QPT News and Ratings via Email Sign-up to receive the latest news and ratings for QPT and its competitors with MarketBeat's FREE daily newsletter. TSXV:QPT Rates by TradingView Quest PharmaTech (CVE:QPT) Frequently Asked Questions How has Quest PharmaTech's stock been impacted by COVID-19 (Coronavirus)? Quest PharmaTech's stock was trading at C$0.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, QPT stock has increased by 0.0% and is now trading at C$0.11. View which stocks have been mosted impacted by Coronavirus. When is Quest PharmaTech's next earnings date? Quest PharmaTech is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for Quest PharmaTech. Has Quest PharmaTech been receiving favorable news coverage? News stories about QPT stock have been trending very negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Quest PharmaTech earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutQuest PharmaTech. Who are some of Quest PharmaTech's key competitors? Some companies that are related to Quest PharmaTech include Burcon NutraScience (BU), IMV (IMV), Ampio Pharmaceuticals (AMPE), Biotron (BIT), Oncolytics Biotech (ONC), Cynata Therapeutics (CYP), Sirona Biochem (SBM), Pediapharm (PDP), Circassia Pharmaceuticals (CIR), Senesco Technologies (ELOX), Orgenesis (ORGS), Orthocell (OCC), Immunoprecise Antibodies (IPA), Medlab Clinical (MDC) and Tiziana Life Sciences (TILS). What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Aphria (APHA) and Canadian Metals (CME). Who are Quest PharmaTech's key executives? Quest PharmaTech's management team includes the following people: Dr. Ragupathy Madiyalakan, CEO & DirectorMr. Pierre Vermette, Chief Financial OfficerMr. Thomas Woo, VP of Product Devel.Mr. Roger Andrews, Head of Investor Relations & Corp. CommunicationsMr. Douglas C. Bachman, VP of Corp. Devel. (Age 65) What is Quest PharmaTech's stock symbol? Quest PharmaTech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "QPT." How do I buy shares of Quest PharmaTech? Shares of QPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Quest PharmaTech's stock price today? One share of QPT stock can currently be purchased for approximately C$0.11. How big of a company is Quest PharmaTech? Quest PharmaTech has a market capitalization of C$18.41 million and generates C$38,871.00 in revenue each year. View additional information about Quest PharmaTech. What is Quest PharmaTech's official website? The official website for Quest PharmaTech is http://www.questpharmatech.com/. How can I contact Quest PharmaTech? Quest PharmaTech's mailing address is 8123 Roper Rd NW, EDMONTON, AB T6E 6S4, Canada. The company can be reached via phone at +1-780-4481400. This page was last updated on 4/4/2020 by MarketBeat.com StaffFeatured Article: How Do I Invest in Dividend Stocks
